Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New dopamine D3 ligand from Warner-Lambert

April 19, 1996

P&U's U-99363E shows high affinity for D4 receptors

April 19, 1996

Warner-Lambert reports NPY1 antagonist

April 19, 1996

NU-1064 and NU-1076, PARP inhibitors

April 19, 1996

Dipyridamole analogue more potent than parent drug

April 19, 1996

Cancer Research Center, Moscow, presents MDR inhibitors at NCI-EORTC

April 19, 1996

Agouron continues to discover MMP inhibitors

April 19, 1996

PD-154309 revealed at 211th ACS

April 19, 1996

AntiCancer, Celltech present gelatinase A inhibitor at NCI-EORTC

April 19, 1996

Alnorin reported in phase I

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...